Summary of the safety profile:
Headache, abdominal pain, diarrhoea and nausea are among those adverse reactions that have been most commonly reported in clinical trials (and also from post-marketing use). In addition, the safety profile is similar for different formulations, treatment indications, age groups and patient populations. No dose-related adverse reactions have been identified.
The reactions are classified according to frequency: Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Blood and lymphatic system disorders:
Rare: Leukopenia, thrombocytopenia.
Very rare: Agranulocytosis, pancytopenia.
Immune system disorders:
Rare: Hypersensitivity reactions e.g. fever, angioedema and anaphylactic reaction/shock.
Metabolism and nutrition disorders:
Uncommon: Peripheral oedema.
Not known: Hypomagnesaemia; severe hypomagnesaemia can correlate with hypocalcaemia. Hypomagnesaemia may also be associated with hypokalaemia.
Rare: Agitation, confusion, depression.
Very rare: Aggression, hallucinations.
Nervous system disorders:
Uncommon: Dizziness, paraesthesia, somnolence.
Rare: Taste disturbance.
Rare: Blurred vision.
Ear and labyrinth disorders:
Respiratory, thoracic and mediastinal disorders:
Common: Abdominal pain, constipation, diarrhoea, flatulence, nausea/vomiting, fundic gland polyps (benign).
Uncommon: Dry mouth.
Rare: Stomatitis, gastrointestinal candidiasis.
Not known: Microscopic colitis.
Uncommon: Increased liver enzymes.
Rare: Hepatitis with or without jaundice.
Very rare: Hepatic failure, encephalopathy in patients with pre-existing liver disease.
Skin and subcutaneous tissue disorders:
Uncommon: Dermatitis, pruritus, rash, urticaria.
Rare: Alopecia, photosensitivity.
Very rare: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN).
Not known: Subacute cutaneous lupus erythematosus.
Musculoskeletal and connective tissue disorders:
Uncommon: Fracture of the hip, wrist or spine.
Rare: Arthralgia, myalgia.
Very rare: Muscular weakness.
Renal and urinary disorders:
Very rare: Interstitial nephritis; in some patients renal failure has been reported concomitantly.
Reproductive system and breast disorders:
Very rare: Gynaecomastia.
General disorders and administration site conditions:
Rare: Malaise, increased sweating.